|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: PENOBSCOT SHOE CO, PREM14C, 1999-12-14 |
Next: PFIZER INC, 8-K, 1999-12-14 |
SECURITIES AND EXCHANGE
COMMISSION |
||
FORM 8-K |
||
|
|
||
|
SECURITIES EXCHANGE ACT OF 1934 |
||
|
Date of earliest event reported: December 8, 1999 |
||
|
(Exact name of registrant as specified in its charter) |
||
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
New York, New York (Address of principal executive offices) |
10017
(Zip Code) |
|
|
(212) 573-2323 |
||
Item 5. Other EventsAttached and incorporated herein by reference as Exhibit 99.1 is a copy of an advertisement published by Pfizer Inc. on December 8, 1999 discussing its proposed merger with Warner-Lambert Company which appeared in major news publications, including The New York Times and The Wall Street Journal. This Current Report on Form 8-K contains or incorporates by reference forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results. Readers are referred to the documents filed by Pfizer with the Securities and Exchange Commission, which identify important risk factors that could cause actual results to differ from those contained in any forward-looking statements. |
Item 7(c). Exhibits |
||
|
|
Advertisement of Pfizer Inc. published on December 8, 1999. |
|
SIGNATURE |
PFIZER INC. |
|
| Dated: December 14, 1999 |
By: /s/ MARGARET M.
FORAN
|
Index to Exhibits |
|
|
|
Advertisement of Pfizer Inc. published on December 8, 1999.
|
|
|